Company intelligence / Profile preview

KinDyn Consulting

Norwich, Norfolk, United Kingdom

Ownership: Private
Development stage: Other

Overview

KinDyn Consulting was a private UK life sciences consulting company focused on pharmacokinetics (PK) and pharmacodynamics (PD) support for the biopharmaceutical industry. The firm advised on both small molecular weight new chemical entities and biologics across multiple phases of drug development, helping clients apply PK/PD principles to guide development decisions. KinDyn was part of the Integrated Biologix network of specialist biopharma consultancies. It appears to have operated as a services business rather than a drug developer, with no disclosed proprietary clinical pipeline. The company was dissolved in April 2025.

Modalities: Small moleculeBiologic
Industry: Consulting

Partnerships

Integrated Biologix networkLYO-X

Beyond the preview

Go deeper on KinDyn Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KinDyn Consulting.

Explore the full profile